Skip to main content
logo
Chimeric Therapeutics Limited (ASX:CHM)
Australia flag Australia · Delayed Price · Currency is AUD
0.0430
+0.0030 (7.50%)
Aug 5, 2026, 4:10 PM AEST

Chimeric Therapeutics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
2818193996
Market Cap Growth
-79.89%-53.99%-9.01%-50.79%-59.22%-
Enterprise Value
-03141626101
Last Close Price
0.040.401.903.628.7626.62

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
0.230.642.354.2714.95-
PB Ratio
-0.754.087.093.401.523.82
P/TBV Ratio
----3.258.49

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
-0.241.883.479.82-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Debt / Equity Ratio
0.83-2.92-1.24-0.42-0.71-0.89
Net Debt / EBITDA Ratio
0.591.060.270.101.351.60
Net Debt / FCF Ratio
0.300.790.410.141.402.53
Asset Turnover
0.790.690.400.160.07-
Quick Ratio
0.680.710.310.612.333.05
Current Ratio
0.690.720.320.642.353.08
Return on Equity (ROE)
-1290.99%-469.35%-308.21%-165.25%-62.55%-120.59%
Return on Assets (ROA)
-26.96%-22.01%-40.86%-54.54%-25.52%-50.84%
Return on Capital Employed (ROCE)
365.20%-93.20%-237.70%-325.20%-56.40%-50.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-821.60%-129.40%-71.52%-134.60%-40.63%-15.75%
FCF Yield
-371.41%-90.26%-43.02%-84.69%-33.65%-9.22%
Buyback Yield / Dilution
-169.62%-94.34%-60.57%-20.37%-97.88%-